Transplacental intrauterine transfusion, a treatment used in HDFN, may increase antibody levels, particularly in those with anterior placenta.

Standard hemoglobin screening may miss iron deficiency that could affect maternal health and newborn blood outcomes, including HDFN.

A pregnant woman’s rare anti-Lub antibody, which can trigger mild HDFN, went undetected due to limited medical record connectivity between health systems. Improved data sharing across blood banks ...

A recently published case study describes a mother with both anti-C and anti-D antibodies who delivered male twins with HDFN, one of whom experienced a severe disease course. Although the most common ...

Courtesy Getty Images If left untreated, jaundice can lead to kernicterus, which requires urgent medical attention and comes with great risk to an infant. Neonatal jaundice, also called ...

Courtesy Getty Images If your infant has a blood transfusion, their blood type may temporarily change, but it will eventually return to its original type. Babies with hemolytic disease of the fetus ...

Despite being uncommon, weak D antigen may still lead to complications associated with HDFN. Aside from the binary view of Rhesus-compatibility as being determined by the presence/absence of Rhesus ...

Courtesy Getty Images Cases of HDFN can vary from mild to severe, with the worst outcomes including fetal mortality and stillbirth. Medical advances in prenatal screening and early diagnosis and ...

Courtesy Getty Images Find out everything you need to know about routine antenatal screening in hemolytic disease of the fetus and newborn (HDFN). In HDFN, there is a mismatch between a mother’s and ...

A medical worker examines blood samples in a lab/Getty Images Before an infant can be treated for HDFN, a ferritin test is often required to measure iron levels in the infant's blood. As a rare red ...